clinical trial · NCT06619847
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
Vertex Pharmaceuticals Incorporated·phase2·completed·n = 367
Acute PainVX-993HB/APAPPlacebo (matched to VX-993)Placebo (matched to HB/APAP)
brief summary
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
started
Oct 29, 2024
primary completion
May 27, 2025
completion
May 27, 2025
last updated
Jun 26, 2025
official title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol